Grant: CIHR Fellowship
University of Toronto
$135,000.00
Systematic identification and characterization of neuronal alternative splicing networks underlying nervous system development and disorders
FY 2017-18
Summary
Autism spectrum disorder (ASD) is a prevalent group of neurodevelopmental disorders that impairs the ability of affected individuals to communicate and interact. ASD is remarkably heterogeneous in terms of its clinical presentation as well as its genetic etiologies. A major current challenge is to identify common molecular mechanisms and pathways that underlie ASD. Recent studies from our laboratory have shown that alternative splicing (AS) is frequently misregulated in brains of autistic individuals. AS is the process by which segments (i.e. exons) from a given gene, are differentially assembled to produce multiple gene products and thus greatly expands the RNA and protein repertoires of cells. AS is particularly prevalent in the nervous system. However, the functions of the vast majority of neuronal AS events and how these impact neurological disorders including ASD is not known.
Accordingly, a major goal of biomedical research is to systematically determine the role of neural-specific exons in the context of nervous system development and neurological disorders. This aim forms the basis of this CIHR fellowship proposal. To accomplish this goal, I have developed a novel CRISPR-based screening platform enabling for the first time the systematic identification of phenotypically important exons. I will apply this technology in order to investigate the function of thousands of alternative exons in the formation of neurons. The most critical exons will be further characterized by a unique combination of genome-wide assays, biochemical experiments and animal models.
The research described in my proposal represents the first systematic approach for investigating the biological function of alternative exons in nervous system development. My research is expected to provide insights into the mechanisms underlying neurodevelopmental disorders such as ASD and holds promise for identifying novel therapeutic targets, which will be of considerable benefit to Canadians.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
377052
Name
Gonatopoulos-Pournatzis Thomas
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Systematic identification and characterization of neuronal alternative splicing networks underlying nervous system development and disorders
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Alternative Splicing; Autism Spectrum Disorder; Crispr Screens; Functional Genomics; High-Throughput Sequencing; Post-Transcriptional Gene Regulation; Systematic Approaches; Translational Control
Abstract
Autism spectrum disorder (ASD) is a prevalent group of neurodevelopmental disorders that impairs the ability of affected individuals to communicate and interact. ASD is remarkably heterogeneous in terms of its clinical presentation as well as its genetic etiologies. A major current challenge is to identify common molecular mechanisms and pathways that underlie ASD. Recent studies from our laboratory have shown that alternative splicing (AS) is frequently misregulated in brains of autistic individuals. AS is the process by which segments (i.e. exons) from a given gene, are differentially assembled to produce multiple gene products and thus greatly expands the RNA and protein repertoires of cells. AS is particularly prevalent in the nervous system. However, the functions of the vast majority of neuronal AS events and how these impact neurological disorders including ASD is not known.
Accordingly, a major goal of biomedical research is to systematically determine the role of neural-specific exons in the context of nervous system development and neurological disorders. This aim forms the basis of this CIHR fellowship proposal. To accomplish this goal, I have developed a novel CRISPR-based screening platform enabling for the first time the systematic identification of phenotypically important exons. I will apply this technology in order to investigate the function of thousands of alternative exons in the formation of neurons. The most critical exons will be further characterized by a unique combination of genome-wide assays, biochemical experiments and animal models.
The research described in my proposal represents the first systematic approach for investigating the biological function of alternative exons in nervous system development. My research is expected to provide insights into the mechanisms underlying neurodevelopmental disorders such as ASD and holds promise for identifying novel therapeutic targets, which will be of considerable benefit to Canadians.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gonatopoulos-Pournatzis, Thomas
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~